Letynol (Cefotaxime Sodium)

Cefotaxime sodium, a third‑generation cephalosporin, is used to treat serious bacterial infections across several organ systems.

• Severe bacterial infections: delivers rapid bactericidal action to eradicate the causative organisms.
• Lower respiratory tract infections: improves clinical outcomes in pneumonia and bronchitis caused by susceptible pathogens.
• Urinary tract infections: eliminates Gram‑negative uropathogens resistant to older agents.
• Meningitis: achieves therapeutic concentrations in cerebrospinal fluid to treat central nervous system infections.
• Skin and soft tissue infections: resolves cellulitis and wound infections caused by susceptible bacteria.

• Cefotaxime sodium exerts its antibacterial effect by binding to penicillin‑binding proteins (PBPs) on the bacterial cell wall, inhibiting the final transpeptidation step of peptidoglycan synthesis. This disruption weakens the cell wall, leading to osmotic instability and bacterial lysis. The molecule is resistant to many β‑lactamases, extending its activity against a broad range of Gram‑negative and some Gram‑positive organisms.

Cefotaxime sodium may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Diarrhea: mild to moderate loose stools.
• Nausea: transient feeling of queasiness.
• Vomiting: occasional emesis.
• Injection site pain: local discomfort or erythema.
• Rash: non‑specific skin eruption.
• Elevated liver enzymes: transient increase in transaminases.

Serious or Rare Side Effects

• Anaphylaxis: severe allergic reaction with respiratory distress.
• Clostridioides difficile‑associated diarrhea: severe colitis.
• Neutropenia: marked reduction in neutrophil count.
• Thrombocytopenia: low platelet levels.
• Renal impairment: acute kidney injury.
• Stevens‑Johnson syndrome: severe mucocutaneous reaction.

When using Letynol, several precautionary measures should be observed to ensure safe administration.

• Renal function: assess and adjust dose in patients with impaired renal clearance.
• Allergy: avoid in individuals with known hypersensitivity to cephalosporins or penicillins.
• Pregnancy: consider only if potential benefits outweigh potential risks.
• Concomitant nephrotoxic drugs: monitor renal function closely.
• Superinfection: watch for secondary infections such as fungal overgrowth.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Cefotaxime sodium can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid)

• Probenecid: reduces renal excretion, increasing cefotaxime plasma levels.
• Aminoglycosides: combined use may heighten risk of nephrotoxicity.
• Warfarin: may potentiate anticoagulant effect, increasing bleeding risk.

Moderate Interactions (Monitor Closely)

• Oral contraceptives: possible reduction in hormonal efficacy.
• Diuretics: may affect renal clearance of cefotaxime.
• Other β‑lactam antibiotics: additive toxicity, especially neurotoxicity.